Host defense mechanisms in invasive candidiasis originating in the GI tract

References

• Koh AY, Köhler JR, Coggshall KT, Van Rooijen N, Pier GB. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog.4(2), e35 (2008).
   PubMed Web of Science ®Google Scholar
• Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med. Mycol.45, 321–346 (2007).
   PubMed Web of Science ®Google Scholar
• Pappas PG. Invasive candidiasis. Infect. Dis. Clin. North Am.20, 485–506 (2006).
   PubMed Web of Science ®Google Scholar
• Blumberg HM, Jarvis WR, Soucie JM et al. Risk factors for Candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin. Infect. Dis.33, 177–186 (2001).
   PubMed Web of Science ®Google Scholar
• Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect. Dis.3, 685–702 (2003).
   PubMed Web of Science ®Google Scholar
• Nucci M, Anaissie E. Revisiting the source of candidemia: skin or gut? Clin. Infect. Dis.33, 1959–1967 (2001).
   PubMed Web of Science ®Google Scholar
• Blijlevens NM, Donnelly JP, de Pauw BE. Microbiologic consequences of new approaches to managing hematologic malignancies. Rev. Clin. Exp. Hematol.9, e2 (2005).
   PubMedGoogle Scholar
• Samonis G, Gikas A, Toloudis P et al. Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut. Eur. J. Clin. Microbiol. Infect. Dis.13, 665–667 (1994).
   PubMed Web of Science ®Google Scholar
• Kumamoto CA, Vinces MD. Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence. Cell. Microbiol.7, 1546–1554 (2005).
   PubMed Web of Science ®Google Scholar
• Sandovsky-Losica H, Barr-Nea L, Segal E. Fatal systemic candidiasis of gastrointestinal origin: an experimental model in mice compromised by anti-cancer treatment. J. Med. Vet. Mycol.30, 219–231 (1992).
   PubMedGoogle Scholar
• Mellado E, Cuenca-Estrella M, Regadera J, González M, Díaz-Guerra TM, Rodríguez-Tudela JL. Sustained gastrointestinal colonization and systemic dissemination by Candida albicans, Candida tropicalis and Candida parapsilosis in adult mice. Diagn. Microbiol. Infect. Dis.38, 21–28 (2000).
   PubMed Web of Science ®Google Scholar
• Takahashi K, Kita E, Konishi M et al. Translocation model of Candida albicans in DBA-2/J mice with protein calorie malnutrition mimics hematogenous candidiasis in humans. Microb. Pathog.35, 179–187 (2003).
   PubMed Web of Science ®Google Scholar
• Yordanov M, Dimitrova P, Patkar S et al. Ibogaine reduces organ colonization in murine systemic and gastrointestinal Candida albicans infections. J. Med. Microbiol.54, 647–653 (2005).
   PubMed Web of Science ®Google Scholar
• Clemons KV, Gonzalez GM, Singh G et al. Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs. Antimicrob. Agents Chemother.50, 2650–2657 (2006).
   PubMed Web of Science ®Google Scholar
• Tournu H, Serneels J, Van Dijck P. Fungal pathogens research: novel and improved molecular approaches for the discovery of antifungal drug targets. Curr. Drug Targets6, 909–922 (2005).
   PubMed Web of Science ®Google Scholar
• Niscola P, Romani C, Cupelli L et al. Mucositis in patients with hematologic malignancies: an overview. Haematologica92, 222–231 (2007).
   PubMed Web of Science ®Google Scholar
• Toruner M, Loftus EV Jr, Harmsen WS et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology134, 929–936 (2008).
   PubMed Web of Science ®Google Scholar
• Bertagnolio S, de Gaetano Donati K, Tacconelli E et al. Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcome. J. Chemother.16, 172–178 (2004).
   PubMed Web of Science ®Google Scholar
• Bendel CM, Hess DJ, Garni RM, Henry-Stanley M, Wells CL. Comparative virulence of Candida albicans yeast and filamentous forms in orally and intravenously inoculated mice. Crit. Care Med.31, 501–507 (2003).
   PubMed Web of Science ®Google Scholar
• Romani L, Puccetti P. Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism. Trends Microbiol.14, 183–189 (2006).
   PubMed Web of Science ®Google Scholar
• Hope WW, Warn PA, Sharp A et al. Surface response modeling to examine the combination of amphotericin B deoxycholate and 5-fluorocytosine for treatment of invasive candidiasis. J. Infect. Dis.192, 673–680 (2005).
   PubMed Web of Science ®Google Scholar
• Andes D, Safdar N, Marchillo K, Conklin R. Pharmacokinetic–pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models. Antimicrob. Agents Chemother.50, 674–684 (2006).
   PubMed Web of Science ®Google Scholar
• Najvar LK, Bocanegra R, Wiederhold NP et al. Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice. Clin. Microbiol. Infect.14, 595–600 (2008).
   PubMed Web of Science ®Google Scholar
• MacCallum DM, Odds FC. Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. Mycoses48, 151–161 (2005).
   PubMed Web of Science ®Google Scholar
• Spellberg B, Ibrahim AS, Edwards JE Jr, Filler SG. Mice with disseminated candidiasis die of progressive sepsis. J. Infect. Dis.192, 336–343 (2005).
   PubMed Web of Science ®Google Scholar
• Maertens J. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies. Eur. J. Haematol.78, 275–282 (2007).
   PubMed Web of Science ®Google Scholar
• Marr KA. Invasive Candida infections: the changing epidemiology. Oncology (Williston Park).18(14 Suppl. 13), 9–14 (2004).
   PubMedGoogle Scholar